drugset / Trial / NCT01231607
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this six month study is to show that dutasteride is safe and more effective than placebo, and at least as safe and effective as finasteride in treating hair loss in men with androgenetic alopecia. Three doses of dutasteride will be investigated.
Timeline
- Start
- 2010-10-28
- Primary completion
- 2012-02-01
- Completion
- 2012-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dutasteride | Small molecule | 0.02 mg | Oral |
| Comparator | Dutasteride | Small molecule | 0.1 mg | Oral |
| Comparator | Dutasteride | Small molecule | 0.5 mg | Oral |
| Comparator | Finasteride | Small molecule | 1 mg | Oral |